semaglutide and methotrexate Millions using weight-loss drug copycats despite being riskier Millions are trying FDA-authorized alternatives

42,43 Several GLP-1R agonists, including exenatide, liraglutide, and semaglutide, have been used in NASH clinical research

The data is delivered through the Noom app alongside the platforms habit-building tools

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 17.99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 99.00 per year only 8.25 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

A large meta-analysis found that GLP-1 drugs dont raise depression or suicidality and modestly boost quality of life and eating control in diabetes/obesity